How much funding has Erasca raised?

Erasca has raised $64.0M in total funding, most recently a Series A round.

Who are Erasca's investors?

Erasca's investors include City Hill Ventures, Cormorant Asset Management, ARCH Venture Partners, Andreessen Horowitz.

Where is Erasca headquartered?

Erasca is headquartered in San Diego, California, United States.

Erasca

IPO

To erase cancer.

Public · San Diego, United States · Founded 2018 · $64.0M raised

Healthcare

Headquarters: San Diego, California
Employees: 51–200
Founded: 2018
Business Model: B2B
Website: erasca.com

Total Funding: $64.0M
Last Round: $64.0M Series AMar 2019
Rounds: 1
Type: Public

About

Erasca is a clinical-stage precision oncology company co-founded in 2018 with a singular mission to erase cancer. The company develops novel therapies targeting the RAS/MAPK pathway, the most frequently altered signaling pathway in cancer, using small molecules, large molecules, and protein degraders in combination to comprehensively shut down oncogenic signaling across multiple tumor types.

Summary

Erasca is a Healthcare company based in San Diego, United States, founded in 2018. It has raised $64.0M in total across 1 round, most recently a $64.0M Series A round in Mar 2019. Investors include City Hill Ventures, Cormorant Asset Management and ARCH Venture Partners.

LinkedIn X (Twitter)